Laffan MA - Search Results

1

Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19.

Turecek PL, Peck RC, Rangarajan S, Reilly-Stitt C, Laffan MA, Kazmi R, James I, Dushianthan A, Schrenk G, Gritsch H, Ewenstein BM, Mellgard B, Erdlenbruch W, Jain N, Binder NB, Mumford AD. Turecek PL, et al. Among authors: laffan ma. Thromb Res. 2021 May;201:100-112. doi: 10.1016/j.thromres.2021.02.012. Epub 2021 Feb 18. Thromb Res. 2021. PMID: 33662796 Free PMC article.

2

Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response.

O'Donnell J, Mumford AD, Manning RA, Laffan M. O'Donnell J, et al. Thromb Haemost. 2000 Jan;83(1):10-3. Thromb Haemost. 2000. PMID: 10669146

3

Fibrinogen Bbeta14 Arg-->Cys: further evidence for a role in thrombosis.

Vakalopoulou S, Mille-Baker B, Mumford A, Manning R, Laffan M. Vakalopoulou S, et al. Blood Coagul Fibrinolysis. 1999 Oct;10(7):403-8. Blood Coagul Fibrinolysis. 1999. PMID: 10695765

4

Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis.

Mumford AD, O'Donnell J, Gillmore JD, Manning RA, Hawkins PN, Laffan M. Mumford AD, et al. Br J Haematol. 2000 Aug;110(2):454-60. doi: 10.1046/j.1365-2141.2000.02183.x. Br J Haematol. 2000. PMID: 10971408 Free article.

5

Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism.

O'Donnell J, Mumford AD, Manning RA, Laffan MA. O'Donnell J, et al. Among authors: laffan ma. Br J Haematol. 2001 Dec;115(3):687-91. doi: 10.1046/j.1365-2141.2001.03146.x. Br J Haematol. 2001. PMID: 11736955 Free article.

6

Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels.

O'Donnell J, Boulton FE, Manning RA, Laffan MA. O'Donnell J, et al. Among authors: laffan ma. Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):335-41. doi: 10.1161/hq0202.103997. Arterioscler Thromb Vasc Biol. 2002. PMID: 11834538

7

A Tyr346-->Cys substitution in the interdomain acidic region a1 of factor VIII in an individual with factor VIII:C assay discrepancy.

Mumford AD, Laffan M, O'Donnell J, McVey JH, Johnson DJ, Manning RA, Kemball-Cook G. Mumford AD, et al. Br J Haematol. 2002 Aug;118(2):589-94. doi: 10.1046/j.1365-2141.2002.03617.x. Br J Haematol. 2002. PMID: 12139751 Free article.

8

Blocking von Willebrand factor: a novel anti-platelet therapy.

Laffan M, McKinnon TA. Laffan M, et al. J Thromb Haemost. 2009 Jul;7(7):1152-4. doi: 10.1111/j.1538-7836.2009.03480.x. Epub 2009 May 8. J Thromb Haemost. 2009. PMID: 19426284 Free article. No abstract available.

9

A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF.

Zanardelli S, Chion AC, Groot E, Lenting PJ, McKinnon TA, Laffan MA, Tseng M, Lane DA. Zanardelli S, et al. Among authors: laffan ma. Blood. 2009 Sep 24;114(13):2819-28. doi: 10.1182/blood-2009-05-224915. Epub 2009 Jul 8. Blood. 2009. PMID: 19587373 Free PMC article.

10

The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs.

Canis K, McKinnon TA, Nowak A, Panico M, Morris HR, Laffan M, Dell A. Canis K, et al. J Thromb Haemost. 2010 Jan;8(1):137-45. doi: 10.1111/j.1538-7836.2009.03665.x. Epub 2009 Oct 24. J Thromb Haemost. 2010. PMID: 19874459 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters